Keyphrases
Peripheral Blood Stem Cell Graft
100%
Post-transplantation Cyclophosphamide (PTCy)
100%
Haploidentical Hematopoietic Stem Cell Transplantation
100%
Donor Lymphocyte Infusion
100%
Graft-versus-host Disease (GvHD)
41%
Chimerism
41%
Peripheral Blood
16%
High Risk
8%
Chemotherapy
8%
Salvage Therapy
8%
Hematologic
8%
First Dose
8%
Relapse Risk
8%
Relapse-free Survival
8%
CD3+ Cells
8%
Donor chimerism
8%
Persistent Disease
8%
Extramedullary Relapse
8%
Bone Marrow Graft
8%
Donor Lymphocytes
8%
G-CSF Mobilized Peripheral Blood
8%
Medicine and Dentistry
Cell Transplantation
100%
Cyclophosphamide
100%
Peripheral Blood Stem Cell
100%
Donor Lymphocyte Infusion
100%
Hematopoietic Cell
100%
Acute Graft Versus Host Disease
25%
Salvage Therapy
8%
Patient History of Chemotherapy
8%
Bone Marrow Transplantation
8%
Recurrence Free Survival
8%
Identified Patient
8%
Granulocyte Colony Stimulating Factor
8%
Chronic Graft Versus Host Disease
8%
CD3 Antigen
8%
Lymphocyte
8%
Diseases
8%
Immunology and Microbiology
Hematopoietic Cell
100%
Cell Transplantation
100%
Peripheral Blood Stem Cell
100%
Cyclophosphamide
100%
Lymphocyte
100%
Acute Graft Versus Host Disease
23%
Chronic Graft Versus Host Disease
7%
Granulocyte Colony-Stimulating Factor
7%
Recurrence Free Survival
7%
CD3 Antigen
7%